Protección inducida por nanococleatos derivados de proteoliposomas de Leptospira interrogans serovar Canicola

whole cell leptospirosis vaccines have been developed and used from the 20`s of last century up today , most of them are not adjuvated and do not confer a long-lasting immunity. these vaccines are mainly against different serogroups of leptospira interrogans contained in the preparation. though several attempts to obtain a vaccinal formulation more effective, purer, with wider spectrum and longer protection than the bacterines of inactivated whole cells have been made no vaccine with these characteristics have been registered yet. this paper deals with the obtainment of outer membrane antigens from a cuban autochthonous strain (strain 87, l. interrogans serovar canicola), by a modification of the technology for the production of outer membrane vesicles, patented by researchers from finlay institute these antigens with nanoproteoliposomic structure were formulated/adjuvated by different strategies, obtaining five preparations with cochlear structures which are nanoparticles of approximately 100 to 150 nm of lenght and from 15 to 30 nm of diameter. two doses of the immunogens are inoculated in the biomodel mesocrisetus aureatus, with an interval of six weeks. the challenge was carried out with 100.000 dl 50 . results showed that the new vaccinal formulations confer protection against the homologous challenge and were able to eliminate the carrier status. this, together with the robutness of the preparation method, the higher level of purity, compared to the bacterines, and the no need of aluminium hydroxide make the formulations an alternative of interest for continuing their development